Company Profile For Anu’s Laboratories Limited

Anu’s Laboratories Limited (ANUL.BO) (Bombay Stock Exchange)

sector: Healthcare · industry: Pharmaceuticals - Generic & Specialty ·

As of 26 Nov 2009

7.92INR

Price Change

-0.20

Percent Change

-2.46%

Analyst Recommendations

Overview

Anu's Laboratories Limited is an India-based company. The Company is engaged in the manufacture and supply of intermediates used in the manufacture of active pharmaceutical ingredients (APIs). The Company is also engaged in contract manufacturing of APIs for selected pharma companies. It also manufactures fine chemicals. The Company’s products includes 2,4 Dichloro 5 Fluoro Acetophenone (DCFA), which is a intermediate for Ciprofloxacin and Enrofloxacin. 6-Chlorohexan-2-One is an intermediate in the manufacturing process of Pentoxifyline, a Vasodilator. Methyl-4 (4-Chloro 1 oxo butyl) a is an intermediate used in the manufacture of Fexofenadine, an anti-allergic drug. Cis(+) Hydroxy Lactum is an advanced intermediate used in the manufacture of Diltiazem Hydrochloride, an antihypertension drug used in the treatment of angina and high blood pressure.

Quick Financial Synopsis

BRIEF: For the six months ended 30 September 2009, Anu's Laboratories Limited's revenues increased 14% to RS948.1M. Net income increased 5% to RS957.1M. Revenues reflect an increase in sale for company's products & services, higher other operating income. Net income was partially offset by an increase in consumption of raw materials, higher employee costs, a rise in depreciation expenses, and an increase in administration, selling & other expenses.